ALCAR Prophylaxis Study

NCT00225160 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections
Distal Symmetric Polyneuropathy

Interventions

DRUG: acetyl L-carnitine

Sponsor

Royal Free Hampstead NHS Trust

Collaborators

[object Object]
[object Object]